,Drug name,Analyte,Specimen,Population,Pregnancy stage,Subject N,Parameter type,Value,Unit,Summary statistics,Variation type,Variation value,Interval type,Lower limit,High limit,P value
0,Meropenem, Meropenem, Plasma, Pediatric, , 28, Unbound plasma concentration at mid-dosing intervals, 19.9, mg/L, Geometric mean, Range, 13.5−29.5, 95% CI, 13.5, 29.5, 
1,Meropenem, Meropenem, Plasma, Pediatric, , 26, Unbound plasma concentration at mid-dosing intervals, 14.8, mg/L, Geometric mean, Range, 11.4−19.1, 95% CI, 11.4, 19.1, 
2,Meropenem, Meropenem, Plasma, Pediatric, , 28, Unbound plasma concentration at end-dosing intervals, 3.5, mg/L, Geometric mean, Range, 2.0−6.1, 95% CI, 2.0, 6.1, 0.04
3,Meropenem, Meropenem, Plasma, Pediatric, , 26, Unbound plasma concentration at end-dosing intervals, 1.6, mg/L, Geometric mean, Range, 1.0−2.6, 95% CI, 1.0, 2.6, 0.04
4,Meropenem, Meropenem, Plasma, Pediatric, , 11, Unbound plasma concentration at mid-dosing intervals, 4.9, mg/L, Geometric mean, Range, 2.6−9.2, 95% CI, 2.6, 9.2, 
5,Meropenem, Meropenem, Plasma, Pediatric, , 7, Unbound plasma concentration at mid-dosing intervals, 1.9, mg/L, Geometric mean, Range, 0.4−9.6, 95% CI, 0.4, 9.6, 
6,Meropenem, Meropenem, Plasma, Pediatric, , 11, Unbound plasma concentration at end-dosing intervals, 0.8, mg/L, Geometric mean, Range, 0.4−1.6, 95% CI, 0.4, 1.6, 
7,Meropenem, Meropenem, Plasma, Pediatric, , 7, Unbound plasma concentration at end-dosing intervals, 0.9, mg/L, Geometric mean, Range, 0.2−4.2, 95% CI, 0.2, 4.2,
